Common Stock, Shares, Outstanding of Milestone Pharmaceuticals Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Milestone Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Milestone Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 85,169,344, a 60% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Milestone Pharmaceuticals Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 85,169,344 +31,841,436 +60% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 53,494,261 +224,696 +0.42% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 53,464,273 +219,108 +0.41% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 53,353,984 +19,870,873 +59% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 53,327,908 +19,846,121 +59% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 53,269,565 +19,905,594 +60% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 53,245,165 +19,907,951 +60% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 33,483,111 -802,891 -2.3% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 33,481,787 +3,093,678 +10% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 33,363,971 +3,358,087 +11% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 33,337,214 +3,419,888 +11% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 34,286,002 +4,388,443 +15% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 30,388,109 +518,324 +1.7% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 30,005,884 +159,884 +0.54% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 29,917,326 +71,326 +0.24% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 29,897,559 +69,562 +0.23% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 29,869,785 +5,142,785 +21% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 29,846,000 +5,153,047 +21% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 29,846,000 +5,286,530 +22% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 29,827,997 +5,322,249 +22% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 24,727,000 +236,258 +0.96% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 24,692,953 +202,211 +0.83% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 24,559,470 +23,944,530 +3894% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 24,505,748 +23,908,961 +4006% 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 24,490,742 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 24,490,742 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 614,940 31 Mar 2019 10-Q 19 Jun 2019 2019 Q1
Q4 2018 596,787 31 Dec 2018 10-K/A 23 Oct 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.